[
  {
    "question_number": "Q202",
    "question_text": "",
    "options": {
      "A": "Guillain-Barr\u00e9 syndrome",
      "B": "Miller Fisher syndrome",
      "C": "Bickerstaff brainstem encephalitis",
      "D": "Multiple sclerosis"
    },
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q217",
    "question_text": "",
    "options": {
      "A": "Continue treatment",
      "B": "Discontinue treatment",
      "C": "Decrease the rate",
      "D": "Administer antihistamines and monitor closely"
    },
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q239",
    "question_text": "",
    "options": {
      "A": "Ach antibodies",
      "B": "Anti-GM1 antibodies",
      "C": "Cortical dementia",
      "D": "Moyamoya disease"
    },
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q240",
    "question_text": "",
    "options": {
      "A": "Miller Fisher syndrome",
      "B": "Bickerstaff brainstem encephalitis",
      "C": "Guillain-Barr\u00e9 syndrome",
      "D": "Multiple sclerosis"
    },
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q246",
    "question_text": "",
    "options": {
      "A": "Multiple sclerosis",
      "B": "Neuromyelitis optica (NMO)",
      "C": "Transverse myelitis",
      "D": "Brain tumor"
    },
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q249",
    "question_text": "",
    "options": {
      "A": "Migraine",
      "B": "Intracranial hemorrhage",
      "C": "Multiple sclerosis",
      "D": "Neuro-Behcet's disease"
    },
    "correct_answer": "D",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q252",
    "question_text": "",
    "options": {
      "A": "Alemtuzumab",
      "B": "Dalfampridine",
      "C": "Dimethyl fumarate",
      "D": "Fingolimod"
    },
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q255",
    "question_text": "",
    "options": {
      "A": "Peripheral brainstem",
      "B": "Inferior temporal pole",
      "C": "Ovoid periventricular",
      "D": "Cerebellar atrophy"
    },
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q258",
    "question_text": "",
    "options": {
      "A": "SSES",
      "B": "VEP",
      "C": "BSEP",
      "D": "MRI"
    },
    "correct_answer": "D",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q259",
    "question_text": "",
    "options": {
      "A": "Cervical region",
      "B": "Thoracic region",
      "C": "Lumbar region",
      "D": "Sacral region"
    },
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q263",
    "question_text": "",
    "options": {
      "A": "Hemiplegic migraine",
      "B": "HaNDL",
      "C": "DAVF",
      "D": "Viral meningitis"
    },
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q264",
    "question_text": "",
    "options": {
      "A": "Lesions in the frontal lobe are most predictive.",
      "B": "Infratentorial and spinal cord lesions are most predictive.",
      "C": "Lesion volume is irrelevant.",
      "D": "Only the number of lesions matters."
    },
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q268",
    "question_text": "",
    "options": {
      "A": "Alemtuzumab",
      "B": "Fingolimod",
      "C": "Natalizumab",
      "D": "Ocrelizumab"
    },
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q270",
    "question_text": "",
    "options": {
      "A": "Contrast enhancement for 3 months",
      "B": "LETM",
      "C": "Multiple small ovoid lesions in periventricular white matter",
      "D": "Dawson\u2019s fingers on MRI"
    },
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q272",
    "question_text": "",
    "options": {
      "A": "Relapsing-Remitting Multiple Sclerosis (RRMS)",
      "B": "Primary Progressive Multiple Sclerosis (PPMS)",
      "C": "Secondary Progressive Multiple Sclerosis (SPMS)",
      "D": "Clinically Isolated Syndrome (CIS)"
    },
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q275",
    "question_text": "",
    "options": {
      "A": "child presents with decreased vision in both eyes, papilledema, and no confusion. An orbital MRI shows anterior bilateral optic nerve enhancement. What is the diagnosis?"
    },
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q284",
    "question_text": "",
    "options": {
      "A": "Adolescent obesity",
      "B": "Epstein-Barr virus seropositivity",
      "C": "Smoking",
      "D": "Vitamin D deficiency"
    },
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q302",
    "question_text": "",
    "options": {
      "A": "52%",
      "B": "58%",
      "C": "60%",
      "D": "65%"
    },
    "correct_answer": "C",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q309",
    "question_text": "",
    "options": {
      "A": "Fingolimod",
      "B": "Interferon",
      "C": "Dalfampridine",
      "D": "Ocrelizumab"
    },
    "correct_answer": "C",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q310",
    "question_text": "",
    "options": {
      "A": "Relapsing-Remitting Multiple Sclerosis (RRMS)",
      "B": "Neuromyelitis Optica (NMO)",
      "C": "Acute Disseminated Encephalomyelitis (ADEM)",
      "D": "Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD)"
    },
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q311",
    "question_text": "",
    "options": {
      "A": "30-year-old man with migraine with incidental periventricular lesion and 2 spine lesions with negative OCB",
      "B": "31-year-old woman with migraine, 4 pericallosal and 3 cerebellar plaques but normal spine",
      "C": "52-year-old woman with demyelinating lesion in the brain and OCB in serum",
      "D": "28-year-old woman with optic neuritis and positive oligoclonal bands in CSF"
    },
    "correct_answer": "B",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q313",
    "question_text": "",
    "options": {
      "A": "Acetazolamide",
      "B": "Carbamazepine",
      "C": "Diazepam",
      "D": "Baclofen"
    },
    "correct_answer": "C",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q316",
    "question_text": "",
    "options": {
      "A": "young patient presents with a history of encephalopathy, weakness, and hearing loss. An MRI of the brain is performed. Which condition is most likely indicated by these symptoms?"
    },
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q331",
    "question_text": "",
    "options": {
      "A": "Intracerebral hemorrhage",
      "B": "Cerebral venous thrombosis",
      "C": "PRES",
      "D": "Lupus Cerebritis"
    },
    "correct_answer": "C",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  },
  {
    "question_number": "Q357",
    "question_text": "",
    "options": {
      "A": "Stop fingolimod",
      "B": "Start steroid",
      "C": "Plasmapheresis (PLEX)",
      "D": "Order ophthalmology evaluation"
    },
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "subspecialty": "Neuroimmunology",
    "explanation": ""
  }
]